wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39257661-07E22988-D202-4B12-80D8-0BEB8DE90AFC
Q39257661-07E22988-D202-4B12-80D8-0BEB8DE90AFC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39257661-07E22988-D202-4B12-80D8-0BEB8DE90AFC
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
P2860
Q39257661-07E22988-D202-4B12-80D8-0BEB8DE90AFC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39257661-07E22988-D202-4B12-80D8-0BEB8DE90AFC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a99b9818c7e0951f561b751be2f5774161f238da
P2860
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.